RE: Novo deal"What do others think about Novo and the possibility of them backing INT in the future?"
IMO I think they have no choice, especially if the results are stellar. I don’t think Novo would want them to partner with another pharma. Remember that E1-INT reduces daily insulin usage and doesn't eliminate it entirely. This will lose them some money on the insulin front but that can be made if E1-INT makes it to market. I think its a win - win situation for Novo.
Anyone want to guess when the news will come out… I say March 5